- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02407379
Diode Laser and SRP in Chronic Periodontitis (PAPD)
Photoablative-photodynamic (PAPD) Diode Laser Therapy Adjunctive to Scaling and Root Planing in Periodontitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present study is a randomized, blinded, controlled clinical trial, which used a split-mouth design. All patients were informed individually about the nature of the proposed treatment, and informed consent forms were signed. Twenty-four patients were studied. Maxillary left or right quadrants were randomly assigned to PAPD laser treatment or sham-treatment and SRP. PAPD consisted of: i) photoablative gingival epithelium with diode laser (λ 810 nm, 1 W); ii) photodynamic treatments (4-10 weekly) with diode laser (λ 635 nm, 100 mW) and 0.3% methylene blue as photoactive antiseptic, performed after SRP. Sham-treatment was similar but with switched off laser.
Efficacy evaluations, including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP) was performed at baseline ,1year, and year 3 using a conventional manual periodontal probe. Polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples at baseline, 6 month and 1, 3, 5 years.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Florence, Italy, 50143
- Odontostomatologic Laser Therapy Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Periodontitis:Presence of at least two teeth with at least one site with pocket probing depth (PD) ranging from 4 to 10 mm in each upper maxillary quadrant and with bleeding on probing (BOP)
- A minimum of five natural teeth in each studied quadrant.
Exclusion Criteria:
- History of systemic diseases (diabetes mellitus, cancer, HIV, metabolic and endocrine diseases)
- Pregnancy or lactation
- Chronic high-dose steroid use
- Previous or current radiation or immunosuppressive therapies
- Ongoing orthodontic treatments
- Extensive carious lesions
- Recurrent antibiotic medications during the 6 months preceding the study
- Class III tooth mobility
- Heavy contamination by spirochetes and fungal pathogens on tongue and oral mucosa
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PAPD+SRP Quadrant
This quadrant, randomly selected in each patients, undergoes treatment with PAPD+ SRP
|
Photoablation of the gingival epithelium was performed with at 810 nm diode laser (1 W output power, continuous wave mode, 66.7 J/cm2, a 0.6 mm optical fiber).
SRP was performed using curettes.
The periodontal tissues and the dental root were rinsed with the photosensitizer agent methylene blue (0.3% w/v in water).
After 5 min., the treated areas were irradiated with at 635 nm diode laser (100 mW output power, continuous wave mode, 0.6 mm optic fiber).
The photodynamic treatment was repeated once weekly until normalization of the cytodiagnostic parameters (range: 4-10 applications).
|
|
Sham Comparator: Sham-laser + SRP
This quadrant, randomly selected in each patients, undergoes treatment with sham-laser + SRP
|
Sham-treatment was similar to the previously described treatment but with switched off laser, followed by scaling and root planing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PD
Time Frame: baseline, 1 year
|
Change in probing pocket depth
|
baseline, 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CAL
Time Frame: baseline, 1 year
|
Change in mean attachment level
|
baseline, 1 year
|
|
BoP
Time Frame: baseline, 1 year
|
Change in mean bleeding on probing
|
baseline, 1 year
|
|
PMN, DEC, bacteria
Time Frame: baseline, 1 year
|
Change in mean additional disease markers, namely polymorphonuclear leukocytes (PMN), erythrocytes (RBC), damaged epithelial cells (DEC) and bacteria were assayed by cytofluorescence on gingival exfoliative samples.
|
baseline, 1 year
|
|
Patient-reported outcomes
Time Frame: baseline, 1 year
|
Individual evaluation of pain/discomfort assessed by a visual analogue score interview
|
baseline, 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Marco Giannelli, Odontostomatologic Laser Therapy Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OLTC014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Akdeniz UniversityNot yet recruitingPeriodontitis (Stage 3) | Periodontitis Stage IVTurkey (Türkiye)
-
Gülnur EmingilEge University Scientific Research Projects Coordination UnitCompletedPeriodontitis (Stage 3) | Periodontitis Stage IIITurkey (Türkiye)
Clinical Trials on PAPD+SRP
-
University of BelgradeCompleted
-
Medical University of BialystokActive, not recruiting
-
University of PisaCompletedDiabetes | PeriodontitisItaly
-
University of PaviaCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
University of LjubljanaUniversity Medical Centre LjubljanaRecruitingPeriodontitisSlovenia
-
Belén Retamal-ValdesActive, not recruiting
-
South Rampart Pharma, LLCNot yet recruiting
-
Yuzuncu Yıl UniversityCompletedAggressive Periodontitis
-
Postgraduate Institute of Dental Sciences RohtakCompleted